These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21747364)

  • 1. Biotechs follow big pharma lead back into academia.
    Kling J
    Nat Biotechnol; 2011 Jul; 29(7):555-6. PubMed ID: 21747364
    [No Abstract]   [Full Text] [Related]  

  • 2. Anthony Coyle.
    Coyle A
    Nat Biotechnol; 2011 Mar; 29(3):187. PubMed ID: 21390006
    [No Abstract]   [Full Text] [Related]  

  • 3. Elias Zerhouni.
    Zerhouni E
    Nat Biotechnol; 2011 Mar; 29(3):188. PubMed ID: 21390007
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiinfective biotechs face partnering gap.
    Sheridan C
    Nat Biotechnol; 2005 Feb; 23(2):155-6. PubMed ID: 15696131
    [No Abstract]   [Full Text] [Related]  

  • 5. Earlier stage biotechs attract partners.
    Ratner M
    Nat Biotechnol; 2005 May; 23(5):509. PubMed ID: 15877052
    [No Abstract]   [Full Text] [Related]  

  • 6. Advice for partnering with pharma.
    Howard K
    Nat Biotechnol; 2004 Nov; 22(11):1477-9. PubMed ID: 15586421
    [No Abstract]   [Full Text] [Related]  

  • 7. Indian biotechs partner with government.
    Jayaraman KS
    Nat Biotechnol; 2009 Apr; 27(4):305. PubMed ID: 19352355
    [No Abstract]   [Full Text] [Related]  

  • 8. Merv Turner.
    Turner M
    Nat Biotechnol; 2011 Mar; 29(3):186. PubMed ID: 21390005
    [No Abstract]   [Full Text] [Related]  

  • 9. Never again.
    Scott C
    Nat Biotechnol; 2010 Feb; 28(2):131. PubMed ID: 20139946
    [No Abstract]   [Full Text] [Related]  

  • 10. A very firm handshake: biotech's growing negotiating power.
    Thiel KA
    Nat Biotechnol; 2005 Oct; 23(10):1221-6. PubMed ID: 16211058
    [No Abstract]   [Full Text] [Related]  

  • 11. The power of many.
    Sansom C
    Nat Biotechnol; 2011 Mar; 29(3):201-3. PubMed ID: 21390017
    [No Abstract]   [Full Text] [Related]  

  • 12. GSK moves on Sirtris.
    Sipp D
    Nat Biotechnol; 2008 Jun; 26(6):595. PubMed ID: 18536662
    [No Abstract]   [Full Text] [Related]  

  • 13. Exiting this year and into the next.
    Nat Biotechnol; 2005 Dec; 23(12):1451. PubMed ID: 16333272
    [No Abstract]   [Full Text] [Related]  

  • 14. Swedish roadtrip.
    Herrera S
    Nat Biotechnol; 2006 Jan; 24(1):15. PubMed ID: 16475247
    [No Abstract]   [Full Text] [Related]  

  • 15. Biotechnology partnerships--medicine for an ailing industry?
    DeLamarter J
    Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
    [No Abstract]   [Full Text] [Related]  

  • 16. Millennium ends Takeda's US shopping spree.
    Sipp D
    Nat Biotechnol; 2008 Jun; 26(6):593-5. PubMed ID: 18536661
    [No Abstract]   [Full Text] [Related]  

  • 17. International regional collaborations are paying off.
    Mitchell P
    Nat Biotechnol; 2004 Nov; 22(11):1475. PubMed ID: 15586420
    [No Abstract]   [Full Text] [Related]  

  • 18. Does biotech M&A benefit investors?
    Jacobs T
    Nat Biotechnol; 2004 Sep; 22(9):1085. PubMed ID: 15340472
    [No Abstract]   [Full Text] [Related]  

  • 19. Study critiques corporate control of trials.
    Niiler E
    Nat Biotechnol; 2002 Dec; 20(12):1180. PubMed ID: 12454659
    [No Abstract]   [Full Text] [Related]  

  • 20. UK biotech sector loses flagship PowderJect to Chiron.
    Mitchell P
    Nat Biotechnol; 2003 Jul; 21(7):717. PubMed ID: 12833073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.